Viewing StudyNCT00378482



Ignite Creation Date: 2024-05-05 @ 5:03 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00378482
Status: COMPLETED
Last Update Posted: 2023-11-14
First Post: 2006-09-19

Brief Title: A Rollover Study for Patients Who Received Tremelimumab in Other Protocols to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued
Sponsor:
Organization: AstraZeneca